Academic Journal
Προβολή σε EDS

Difficulty and Complications of Lead Extraction-Is ICD Lead Design Important?

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Difficulty and Complications of Lead Extraction-Is ICD Lead Design Important?
Συγγραφείς: Kutarski A; 2nd Department of Cardiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland., Jacheć W; 2nd Department of Cardiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland., Stefańczyk P; Department of Cardiology, The Pope John Paul II Province Hospital of Zamość, Zamość, Poland., Tułecki Ł; Department of Cardiac Surgery, The Pope John Paul II Province Hospital of Zamość, Zamość, Poland., Nowosielecka D; Department of Cardiac Surgery, The Pope John Paul II Province Hospital of Zamość, Zamość, Poland.; Faculty of Health Sciences, Academy of Zamość, Zamość, Poland.
Πηγή: Pacing and clinical electrophysiology : PACE [Pacing Clin Electrophysiol] 2026 May; Vol. 49 (5), pp. 563-572. Date of Electronic Publication: 2026 Feb 03.
Τύπος έκδοσης: Journal Article
Γλώσσα: English
Στοιχεία περιοδικού: Publisher: Futura Pub. Co Country of Publication: United States NLM ID: 7803944 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1540-8159 (Electronic) Linking ISSN: 01478389 NLM ISO Abbreviation: Pacing Clin Electrophysiol Subsets: MEDLINE
Imprint Name(s): Original Publication: Mount Kisco, N. Y. : Futura Pub. Co., c1978-
Ιατρικοί όροι (MeSH): Defibrillators, Implantable*/statistics & numerical data , Device Lead Extraction*/statistics & numerical data , Device Lead Extraction*/adverse effects , Device Removal*/adverse effects , Device Removal*/statistics & numerical data , Postoperative Complications*/epidemiology , Electrodes, Implanted*/statistics & numerical data, Humans ; Female ; Male ; Retrospective Studies ; Middle Aged ; Aged ; Equipment Design ; Treatment Outcome ; Risk Factors ; Equipment Failure
Περίληψη: Background: Transvenous removal of implantable cardioverter-defibrillator (ICD) leads is considered to be more difficult and risky. The goal was to explore the impact of ICD lead design on transvenous lead extraction (TLE) safety and effectiveness.
Methods: Analysis of 3929 TLE procedures (including 1068 with ICD lead extraction) were analyzed retrospectively.
Results: The extracted ICD leads were about three years younger than pacemaker (PM) leads (medians: 61.00 vs. 97.00 months). The rate of major TLE complications (MC) was significantly higher in the PM lead extraction group (2.25% vs. 0.75%; p = 0.002) and complete procedural success was achieved significantly less often (by 4.11%; p < 0.001 in entire group of patients and by 3.74%; p < 0.001 in patients matched according to age of extracted lead). However, no significant differences were found in the scores of TLE complexity and major complications during extraction of ICD leads produced by different manufacturers. Lower rates of complete procedural success, compared to Medtronic ICD leads, were found in patients with Abbott and Biotronik ICD leads (99.45% vs. 97.32%; p = 0.009 and 96.65%; p = 0.003).
Conclusions: 1. ICD lead implant duration was 3.17 years shorter and perhaps for this reason ICD lead extraction was often less difficult, the procedure less complex and MC significantly rare (0.75%) in comparison with PM lead extraction (2.55%). There were no differences between groups matched according to age of extracted lead. Achieving of complete procedural success was lower in PM lead extraction both in entire as in matched group of patients. 2. There were no significant differences in the complexity of TLE procedures or the incidence of major complications depending on ICD lead manufacturer, despite the fact that Biotronik leads were 16-19 months older. 3. The extraction of Abbot and Biotronik leads was associated with a lower rate of complete procedural success (by 2.13% and 2.80%).
(© 2026 Wiley Periodicals LLC.)
References: B. L. Wilkoff, C. J. Love, C. L. Byrd, et al., “Transvenous Lead Extraction: Heart Rhythm Society Expert Consensus on Facilities, Training, Indications, and Patient Management: This Document Was Endorsed by the American Heart Association (AHA),” Heart Rhythm 6 (2009): 1085–1104, https://doi.org/10.1016/j.hrthm.2009.05.020.
F. M. Kusumoto, M. H. Schoenfeld, B. Wilkoff, et al., “2017 HRS Expert Consensus Statement on Cardiovascular Implantable Electronic Device Lead Management and Extraction,” Heart Rhythm 14 (2017): e503–e551, https://doi.org/10.1016/j.hrthm.2017.09.001.
J. Neuzner, S. H. Hohnloser, V. Kutyifa, et al., “Effectiveness of Single‐ vs. Dual‐Coil Implantable Defibrillator Leads: An Observational Analysis From the SIMPLE Study,” Journal of Cardiovascular Electrophysiology 30 (2019): 1078–1085, https://doi.org/10.1111/jce.13943.
A. Ząbek, K. Boczar, M. Ulman, et al., “Mechanical Extraction of Implantable Cardioverter‐Defibrillator Leads With a Dwell Time of More Than 10 Years: Insights From a Single High‐Volume Centre,” Europace 25 (2023): 1100–1109, https://doi.org/10.1093/europace/euac272.
M. P. Brunner, E. M. Cronin, V. E. Duarte, et al., “Clinical Predictors of Adverse Patient Outcomes in an Experience of More Than 5000 Chronic Endovascular Pacemaker and Defibrillator Lead Extractions,” Heart Rhythm 11 (2014): 799–805, https://doi.org/10.1016/j.hrthm.2014.01.016.
N. Sunderland, A. Kaura, F. Murgatroyd, P. Dhillon, and P. A. Scott, “Outcomes With Single‐Coil versus Dual‐Coil Implantable Cardioverter Defibrillators: A Meta‐Analysis,” Europace 20 (2018): e21–e29, https://doi.org/10.1093/europace/euw438.
A. P. Benz, M. Vamos, J. W. Erath, P. Bogyi, G. Z. Duray, and S. H. Hohnloser, “ICD Lead Type and RV Lead Position in CRT‐D Recipients,” Clinical Research in Cardiology 107 (2018): 1122–1130, https://doi.org/10.1007/s00392‐018‐1286‐3.
M. G. Bongiorni, H. Burri, J. C. Deharo, et al., “2018 EHRA Expert Consensus Statement on Lead Extraction: Recommendations on Definitions, Endpoints, Research Trial Design, and Data Collection Requirements for Clinical Scientific Studies and Registries: Endorsed by APHRS/HRS/LAHRS,” Europace 00 (2018): 1–11.
B. S. Sidhu, S. Ayis, J. Gould, et al., “Risk Stratification of Patients Undergoing Transvenous Lead Extraction With the ELECTRa Registry Outcome Score (EROS): An ESC EHRA EORP European Lead Extraction ConTRolled ELECTRa Registry Analysis,” Europace 23 (2021): 1462–1471, https://doi.org/10.1093/europace/euab037.
S. K. Agarwal, S. Kamireddy, J. Nemec, A. Voigt, and S. Saba, “Predictors of Complications of Endovascular Chronic Lead Extractions From Pacemakers and Defibrillators: A Single‐Operator Experience,” Cardiovasc Electrophysiol 20 (2009): 171–175, https://doi.org/10.1111/j.1540‐8167.2008.01283.x.
R. G. Hauser, W. T. Katsiyiannis, C. C. Gornick, A. K. Almquist, and L. M. Kallinen, “Deaths and Cardiovascular Injuries Due to Device‐Assisted Implantable Cardioverter‐Defibrillator and Pacemaker Lead Extraction,” Europace 12 (2010): 395–401, https://doi.org/10.1093/europace/eup375.
D. Zweiker, B. El Sawaf, G. D'Angelo, et al., “Step by Step Through the Years‐High vs. Low Energy Lead Extraction Using Advanced Extraction Techniques,” Journal of Clinical Medicine 11 (2022): 4884, https://doi.org/10.3390/jcm11164884.
P. J. Geselle, R. Poesen, F. Rega, et al., “Transvenous Extraction of Pacing and Defibrillator Leads–A Single‐Centre Experience,” Acta Cardiologica 67 (2012): 641–648, https://doi.org/10.1080/AC.67.6.2184666.
B. Małecka, A. Kutarski, and M. Grabowski, “Is the Transvenous Extraction of Cardioverter‐Defibrillator Leads More Hazardous Than That of Pacemaker Leads?,” Kardiologia Polska 68 (2010): 884–890.
S. Pecha, Y. Yildirim, N. Gosau, et al., “Laser Lead Extraction Allows for Safe and Effective Removal of Single‐ and Dual‐Coil Implantable Cardioverter Defibrillator Leads: A Single‐Centre Experience Over 12 Years,” Interact Cardiovasc Thorac Surg 24 (2017): 77–81, https://doi.org/10.1093/icvts/ivw298.
L. Bontempi, A. Curnis, P. Della Bella, et al., “The MB Score: A New Risk Stratification Index to Predict the Need for Advanced Tools in Lead Extraction Procedures,” Europace 22 (2020): 613–621, https://doi.org/10.1093/europace/euaa027.
L. Bontempi, F. Vassanelli, M. Cerini, et al., “Predicting the Difficulty of a Transvenous Lead Extraction Procedure: Validation of the LED Index,” Journal of Cardiovascular Electrophysiology 28 (2017): 811–818, https://doi.org/10.1111/jce.13223.
P. Mazzone, D. Tsiachris, A. Marzi, et al., “Predictors of Advanced Lead Extraction Based on a Systematic Stepwise Approach: Results From a High‐Volume Center,” Pacing and Clinical Electrophysiology 36 (2013): 837–844, https://doi.org/10.1111/pace.12119.
M. P. Brunner, E. M. Cronin, J. Jacob, et al., “Transvenous Extraction of Implantable Cardioverter‐Defibrillator Leads Under Advisory–A Comparison of Riata, Sprint Fidelis, and Non‐Recalled Implantable Cardioverter‐Defibrillator Leads,” Heart Rhythm 10 (2013): 1444–1450, https://doi.org/10.1016/j.hrthm.2013.06.021.
K. Hayashi, T. Callahan, J. Rickard, et al., “Extraction Outcomes of Implantable Cardioverter‐Defibrillator Leads Vary by Manufacturer and Model family,” Europace 25 (2023): euad345, https://doi.org/10.1093/europace/euad345.
E. P. Zeitler, Y. Wang, S. D. Pokorney, J. Curtis, and J. M. Prutkin, “Comparative Outcomes of Riata and Fidelis Lead Management Strategies: Results From the NCDR‐ICD Registry,” Pacing and Clinical Electrophysiology 44 (2021): 1897–1906, https://doi.org/10.1111/pace.14361.
T. D. Richardson, M. J. Kolek, S. K. Goyal, et al., “Comparative Outcomes of Transvenous Extraction of Sprint Fidelis and Riata Defibrillator Leads: A Single Center Experience,” Journal of Cardiovascular Electrophysiology 25 (2014): 36–42, https://doi.org/10.1111/jce.12265.
A. Kutarski, W. Jacheć, P. Stefańczyk, W. Brzozowski, A. Głowniak, and D. Nowosielecka, “Analysis of 1051 ICD Leads Extractions in Search of Factors Affecting Procedure Difficulty and Complications: Number of Coils, Tip Fixation and Position‐Does It Matter?,” Journal of Clinical Medicine 13 (2024): 1261, https://doi.org/10.3390/jcm13051261.
A. Kutarski, M. Czajkowski, R. Pietura, et al., “Effectiveness, Safety, and Long‐Term Outcomes of Non‐Powered Mechanical Sheaths for Transvenous Lead Extraction,” Europace 20 (2018): 1324–1333, https://doi.org/10.1093/europace/eux218.
J. Kosior, W. Jacheć, A. Polewczyk, et al., “To Grade or Not to Grade Safety Requirements for Transvenous Lead Extraction: Experience With 2216 Procedures,” Kardiologia Polska 81 (2023): 242–251, https://doi.org/10.33963/KP.a2022.0266.
A. Kutarski, W. Jacheć, M. Czajkowski, et al., “Lead Break During Extraction: Predisposing Factors and Impact on Procedure Complexity and Outcome: Analysis of 3825 Procedures,” Journal of Clinical Medicine 13 (2024): 2349, https://doi.org/10.3390/jcm13082349.
W. Jacheć, D. Nowosielecka, B. Ziaja, A. Polewczyk, and A. Kutarski, “LECOM (Lead Extraction COMplexity): A New Scoring System for Predicting a Difficult Procedure,” Journal of Clinical Medicine 12 (2023): 7568.
A. Kutarski, W. Jacheć, D. Nowosielecka, and A. Polewczyk, “Unexpected Procedure Difficulties Increasing the Complexity of Transvenous Lead Extraction: The Single Centre Experience With 3721 Procedures,” Journal of Clinical Medicine 12 (2023): 2811, https://doi.org/10.3390/jcm12082811.
T. Koike, M. Shoda, K. Ejima, et al., “Impact of Fracture‐Prone Implantable Cardioverter Defibrillator Leads on Long‐Term Patient Mortality,” Journal of Arrhythmia 39 (2023): 454–463, https://doi.org/10.1002/joa3.12843.
S. Kawada, N. Nishii, Y. Morimoto, et al., “Comparison of Longevity and Clinical Outcomes of Implantable Cardioverter‐Defibrillator Leads Among Manufacturers,” Heart Rhythm 14 (2017): 1496–1503, https://doi.org/10.1016/j.hrthm.2017.05.020.
D. Pérez Díez, J. M. Rubín, D. Calvo Cuervo, D. García Iglesias, and C. Morís De La Tassa, “Analysis of Early Failure of Biotronik Linox Smart Implantable Cardioverter‐Defibrillator Leads: A Comparative Study of Three Defibrillator Leads,” Pacing and Clinical Electrophysiology 41 (2018): 1165–1170.
R. Providência, D. B. Kramer, D. Pimenta, et al., “Transvenous Implantable Cardioverter‐Defibrillator (ICD) Lead Performance: A Meta‐Analysis of Observational Studies,” Journal of the American Heart Association 4 (2015): e002418, https://doi.org/10.1161/JAHA.115.002418.
S. C. van Malderen, T. Szili‐Torok, S. C. Yap, S. E. Hoeks, F. Zijlstra, and D. A. Theuns, “Comparative Study of the Failure Rates Among 3 Implantable Defibrillator Leads,” Heart Rhythm 13 (2016): 2299–2305.
A. Lam, S. Buehler, E. Goulouti, et al., “Comparison of Lead Failure Manifestation of Biotronik Linox With St. Jude Medical Riata and Medtronic Sprint Fidelis Lead,” Journal of Interventional Cardiac Electrophysiology 54 (2019): 161–170, https://doi.org/10.1007/s10840‐018‐0486‐0.
K. Hayashi, T. Callahan, J. Rickard, et al., “Comparison of Outcomes and Required Tools Between Transvenous Extraction of Pacemaker and Implantable Cardioverter Defibrillator Leads: Insight From Single High‐Volume Center Experience,” Journal of Cardiovascular Electrophysiology 35 (2024): 1382–1392, https://doi.org/10.1111/jce.16294.
Grant Information: BNW-1-018/N/5/K Medical University of Silesia in Katowice, Poland
Contributed Indexing: Keywords: ICD lead extraction complexity; ICD lead models; complications of ICD lead extraction; difficulties of ICD lead extraction
Entry Date(s): Date Created: 20260203 Date Completed: 20260706 Latest Revision: 20260706
Update Code: 20260707
DOI: 10.1111/pace.70144
PMID: 41631601
Βάση Δεδομένων: MEDLINE
Περιγραφή
ISSN:1540-8159
DOI:10.1111/pace.70144